Pancragen Research Hub | QSC — Pancreatic Bioregulator
QSC · RESEARCH CATALOG
Pancragen Research Hub ≥99% HPLC · Janoshik Independent COA · US-Based · Research Use Only
Pancragen (Lys-Glu) is a synthetic dipeptide bioregulator from the Khavinson Institute, derived from pancreatic tissue extracts (Pancramax/Pancragen). It is studied for pancreatic function modulation, insulin secretion regulation, and metabolic panel effects in aging models. Research interest has increased with the GLP-1 agonist wave — Pancragen represents the bioregulator approach to pancreatic function vs the GLP-1R agonist approach. QSC stocks Pancragen at ≥99% HPLC with Janoshik independent COA.
Pancragen (Lys-Glu) is studied for its effects on pancreatic beta cell function, insulin secretion modulation, and glucagon regulation in aging models. Khavinson bioregulator research shows restoration of pancreatic gene expression patterns in aged animal tissues toward youthful profiles.
Khavinson Bioregulator Class
Part of the Khavinson epigenetic bioregulator class — tissue-specific dipeptides and tetrapeptides that modulate chromatin accessibility and gene expression in target tissues. Pancragen targets pancreatic tissue specifically, unlike systemic bioregulators.
Frequently Asked Questions
What is Pancragen?
Pancragen (Lys-Glu) is a synthetic dipeptide bioregulator from the Khavinson Institute studied for pancreatic function modulation and metabolic regulation in aging models. Part of the Khavinson tissue-specific bioregulator class. QSC stocks Pancragen at ≥99% HPLC with Janoshik COA. Research use only.
Does QSC stock Pancragen?
Yes — QSC stocks Pancragen at ≥99% HPLC with Janoshik independent COA, verifiable at verify.janoshik.com. Research use only.
Research Use Only: All QSC products sold strictly for in vitro laboratory research. Not for human or veterinary use. Information on this page is educational and does not constitute medical advice.
